Ebola Virus Glycoprotein Induces an Innate Immune Response In vivo via TLR4
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ebola Virus Glycoprotein Induces an Innate Immune Response In vivo via TLR4
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-08-17
DOI
10.3389/fmicb.2017.01571
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in mice
- (2018) Axel T. Lehrer et al. VACCINE
- Ebola virus disease: An update on current prevention and management strategies
- (2017) M.A. Trad et al. JOURNAL OF CLINICAL VIROLOGY
- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
- (2017) Ana Maria Henao-Restrepo et al. LANCET
- Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection
- (2017) Mathieu Iampietro et al. PLoS Pathogens
- Ebola virus disease candidate vaccines under evaluation in clinical trials
- (2016) Karen A. Martins et al. Expert Review of Vaccines
- Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea
- (2016) Johan van Griensven et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent advances in the development of vaccines for Ebola virus disease
- (2016) Elijah Ige Ohimain VIRUS RESEARCH
- Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
- (2015) Ana Maria Henao-Restrepo et al. LANCET
- The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
- (2015) Angela Huttner et al. LANCET INFECTIOUS DISEASES
- VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain
- (2015) A. Marzi et al. SCIENCE
- Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity
- (2015) Naphak Modhiran et al. Science Translational Medicine
- The Role of Cytokines and Chemokines in Filovirus Infection
- (2015) Sandra Bixler et al. Viruses-Basel
- Mechanisms of Immunity in Post-Exposure Vaccination against Ebola Virus Infection
- (2015) Steven B. Bradfute et al. PLoS One
- Virus-Like Particles Activate Type I Interferon Pathways to Facilitate Post-Exposure Protection against Ebola Virus Infection
- (2015) Natarajan Ayithan et al. PLoS One
- THP-1 cell line: An in vitro cell model for immune modulation approach
- (2014) Wasaporn Chanput et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Shed GP of Ebola Virus Triggers Immune Activation and Increased Vascular Permeability
- (2014) Beatriz Escudero-Pérez et al. PLoS Pathogens
- Ebola Virus-Like Particles Stimulate Type I Interferons and Proinflammatory Cytokine Expression Through the Toll-Like Receptor and Interferon Signaling Pathways
- (2013) Natarajan Ayithan et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Inflammasome Adaptor Protein Apoptosis-Associated Speck-Like Protein Containing CARD (ASC) Is Critical for the Immune Response and Survival in West Nile Virus Encephalitis
- (2013) M. Kumar et al. JOURNAL OF VIROLOGY
- The Lack of Maturation of Ebola Virus-Infected Dendritic Cells Results from the Cooperative Effect of at Least Two Viral Domains
- (2013) N. M. Lubaki et al. JOURNAL OF VIROLOGY
- Therapeutic Intervention of Ebola Virus Infection in Rhesus Macaques with the MB-003 Monoclonal Antibody Cocktail
- (2013) J. Pettitt et al. Science Translational Medicine
- Vaccine Adjuvants: Mode of Action
- (2013) Ennio De Gregorio et al. Frontiers in Immunology
- Mechanisms of Action of Adjuvants
- (2013) Sunita Awate et al. Frontiers in Immunology
- Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease
- (2012) J. M. Dye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mouse Models for Filovirus Infections
- (2012) Steven B. Bradfute et al. Viruses-Basel
- Filovirus Tropism: Cellular Molecules for Viral Entry
- (2012) Ayato Takada Frontiers in Microbiology
- Ebola Virion Attachment and Entry into Human Macrophages Profoundly Effects Early Cellular Gene Expression
- (2011) Victoria Wahl-Jensen et al. PLoS Neglected Tropical Diseases
- Ebola haemorrhagic fever
- (2010) Heinz Feldmann et al. LANCET
- Human Fatal Zaire Ebola Virus Infection Is Associated with an Aberrant Innate Immunity and with Massive Lymphocyte Apoptosis
- (2010) Nadia Wauquier et al. PLoS Neglected Tropical Diseases
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- Interaction between Ebola Virus Glycoprotein and Host Toll-Like Receptor 4 Leads to Induction of Proinflammatory Cytokines and SOCS1
- (2009) A. Okumura et al. JOURNAL OF VIROLOGY
- Reversal of West Nile virus-induced blood–brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor
- (2009) Saguna Verma et al. VIROLOGY
- Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses
- (2008) Dana L Swenson et al. Expert Review of Vaccines
- Recombinant Vesicular Stomatitis Virus Vector Mediates Postexposure Protection against Sudan Ebola Hemorrhagic Fever in Nonhuman Primates
- (2008) T. W. Geisbert et al. JOURNAL OF VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now